Data / Form D filings / Alida Biosciences Inc.
Alida Biosciences Inc.: Form D filings
Alida Biosciences Inc., a biotechnology company in San Diego, CA, filed 3 Form D notices with the SEC between 2021 and 2024. The latest, on June 17, 2024, reports $7.5 million sold of a $8.5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 14813 PRISCILLA STREET, San Diego, CA, 92129
- Phone
- (720) 375-1071
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1870548
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | New notice | $8,520,384 | $7,520,384 | $1,000,000 | 3 | Jun 7, 2024 | sec.gov |
| May 23, 2022 | New notice | $3,999,999 | $3,999,999 | 2 | May 11, 2022 | sec.gov | |
| Jul 2, 2021 | New notice | $1,110,000 | $510,000 | $600,000 | 4 | Jun 21, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Landon Merrill | Director | |
| Gudrun Stengel | Executive Officer, Director | |
| Paul Conley | Director | |
| John Drewry | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 17, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Alida Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.